Locations
Berlin, Germany · Berlin, Germany
industry
Biotechnology · Data and Analytics · DeepTech · Software
Size
11-50 employees
Stage
Seed
founded in
2018
Nostos Genomics is an AI-driven genetic analysis platform that focuses on improving the speed and accuracy of rare disease diagnostics. Their flagship product, AION, automates the interpretation of genetic variants, significantly reducing the time required for diagnosis and enhancing the diagnostic yield by over 50% compared to traditional methods. By leveraging advanced machine learning techniques, Nostos Genomics addresses the bottleneck in genomic interpretation, allowing genetic testing labs to provide faster and more reliable results. The company aims to empower patients and healthcare providers with timely and actionable genetic insights, positioning itself as a leader in the rapidly evolving field of genomics.
Something looks off?